Support the Australian Nuclear Science and Technology Organisation (ANSTO) in its provision of nuclear medicines to Australians.
The Government will provide funding over 10 years from 2023-24 to support the Australian Nuclear Science and Technology Organisation (ANSTO) in its provision of nuclear medicines to Australians, including.
* $44.5 million over 3 years from 2023-24 to support ANSTO to manage the planned upcoming maintenance shutdown of its nuclear reactor, including the importation of nuclear medicine that would ordinarily be produced by the reactor
* $39.9 million over 3 years from 2023-24 to formally wind-up ANSTO Nuclear Medicine Pty Ltd by 1 July 2024 and transfer its operations, assets and liabilities to ANSTO
* Funding over 10 years from 2023-24 for ANSTO to construct a new nuclear medicine manufacturing building, as well as ongoing maintenance of the current ageing facility
* Funding over two years from 2023-24 for ANSTO to develop a business case for a new facility supporting Australia's sovereign nuclear security science capability. The financial implications are not for publication (nfp) due to commercial sensitivities.